Hormonal Potentiation of Imipramine and ECT in Primary Depression
Abstract
A double-blind, controlled study with frequent rating of symptoms, using a homogeneous population of 49 patients with primary depression, was conducted to measure the possible enhancement of imipramine's antidepressant activity by T3 and dexamethasone and the possible enhancement of the antidepressant activity of ECT by dexamethasone. The results of this study, which are clearly negative, raise serious questions as to the efficacy of these hormones in enhancing the antidepressant activity of imipramine and ECT.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).